ERN-EuroBloodNet Registry on Patients With Rare Red Blood Cell Defects and COVID-19

Conditions

• Hemoglobinopathies
• Sickle Cell Disease
• Sickle Cell Anemia
• Sickle Beta Thalassemia
• Sickle-Cell; Hemoglobinopathy
• Sickle Cell Hemoglobin C
• Sickle Cell Hemoglobin D
• Sickle Cell-Hemoglobin E Disease
• Beta-Thalassemia
• Beta Thalassemia Major
• Beta Thalassemia Intermedia
• Dominant Beta-Thalassemia
• Hereditary Persistence of Fetal Hemoglobin Thalassemia
• Delta-Beta Thalassaemia
• Haemoglobin C-Beta-Thalassaemia Syndrome
• Hemoglobin E-Beta Thalassemia
• Alpha-Thalassemia
• Hemoglobin H Disease
• Hemoglobin Barts Hydrops
• Enzyme Disorder; Anemia
• Membranes; Disorder
• Elliptocytosis, Hereditary
• Stomatocytosis
• Spherocytosis, Hereditary

Interventions

• OTHER: Non applicable, is a patient registry

Sponsor

Hospital Universitari Vall d'Hebron Research Institute

Collaborators

• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]